Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
11.45
+0.15 (1.33%)
Mar 13, 2025, 3:51 PM EDT - Market open
Maze Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 |
| Mar '25 Mar 13, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 501 | - | - |
| Enterprise Value | 429 | - | - |
| Debt / Equity Ratio | 0.80 | 4.94 | 0.32 |
| Quick Ratio | 8.52 | 1.79 | 4.81 |
| Current Ratio | 8.77 | 2.09 | 5.11 |
| Return on Equity (ROE) | - | -180.12% | - |
| Return on Assets (ROA) | - | -55.63% | - |
| Return on Capital (ROIC) | - | -63.77% | - |
| Buyback Yield / Dilution | -17.86% | -13.89% | - |
| Total Shareholder Return | -17.86% | -13.89% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.